XML 25 R12.htm IDEA: XBRL DOCUMENT v3.22.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
    The carrying amounts of our financial instruments, including cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value because of their short maturities.
    We follow a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of "observable inputs" and minimize the use of "unobservable inputs." The three levels of inputs used to measure fair value are as follows:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Observable inputs other than quoted prices included in Level 1, such as quoted prices for markets that are not active or other inputs that are observable or can be corroborated by observable market data.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
    The table below segregates all assets that are measured at fair value on a recurring basis (which is measured at least annually) into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
March 31,
2022
Quoted prices
in active markets
for identical
assets (level 1)
Significant other
observable inputs
(level 2)
Significant
unobservable
inputs
(level 3)
Balance Sheet Classification
Bank-time deposits$636,000 $636,000 $— $— Cash and cash equivalents
Money market funds501,903 501,903 — — Cash and cash equivalents
Commercial paper119,377 — 119,377 — Cash and cash equivalents
US Treasuries51,977 51,977 — — Cash and cash equivalents
Certificates of Deposit10,005 — 10,005 — Cash and cash equivalents
Corporate bonds2,801 — 2,801 — Cash and cash equivalents
Money market funds356,830 356,830 — — Restricted cash and cash equivalents
Bank-time deposits531 531 — — Restricted cash and cash equivalents
Corporate Bonds538,460 — 538,460 — Short-term investments
Bank-time deposits131,797 131,797 — — Short-term investments
Commercial paper125,390 — 125,390 — Short-term investments
US Treasuries23,414 23,414 — — Short-term investments
Certificates of Deposit999 — 999 — Short-term investments
Private equity 16,134 — — 16,134 Other assets
Money market funds103,452 103,452 — — Restricted cash and cash equivalents, long term
Foreign currency forward contracts(202)— (202)— Accrued expenses and other current liabilities
Contingent earn-out consideration(66,025)— — (66,025)Accrued expenses and other current liabilities
Contingent earn-out consideration(43,030)— — (43,030)Other long-term liabilities
Total recurring fair value measurements, net$2,509,813 $1,805,904 $796,830 $(92,921)
March 31,
2021
Quoted prices
in active markets
for identical
assets (level 1)
Significant other
observable inputs
(level 2)
Significant
unobservable
inputs
(level 3)
Balance Sheet Classification
Money market funds$837,614 $837,614 $— $— Cash and cash equivalents
Bank-time deposits95,000 95,000 — — Cash and cash equivalents
Commercial paper100,105 — 100,105 — Cash and cash equivalents
Money market funds528,659 528,659 — — Restricted cash and cash equivalents
Bank-time deposits563 563 — — Restricted cash and cash equivalents
Corporate Bonds521,224 — 521,224 — Short-term investments
Bank-time deposits578,762 578,762 — — Short-term investments
US Treasuries60,086 60,086 — — Short-term investments
Commercial paper148,150 — 148,150 — Short-term investments
Asset-backed securities470 — 470 — Short-term investments
Money market funds98,541 98,541 — — Long-term restricted cash and cash equivalents
Private equity7,578 — — 7,578 Other assets
Foreign currency forward contracts(125)— (125)— Accrued expenses and other current liabilities
Total recurring fair value measurements, net$2,976,627 $2,199,225 $769,824 $7,578 
In connection with the Nordeus acquisition (see Note 22 - Acquisitions), we recorded $61,055 as the initial fair value of contingent earn-out consideration. The fair value was estimated using a Monte-Carlo simulation model, which included significant unobservable Level 3 inputs, such as projected financial performance over the earn-out period along with estimates for market volatility and the discount rate applicable to potential cash payouts.
During the fiscal year ended March 31, 2022, we recognized General and administrative expense of $48,000 within our Consolidated Statements of Operations for the increase in fair value of the contingent earn-out consideration liability associated with the Nordeus acquisition, which increased the fair value of the contingent consideration liability to $109,055. The increase resulted from a higher probability of Nordeus achieving certain performance measures in the 12- and 24-month periods following the closing.    
We did not have any transfers between Level 1 and Level 2 fair value measurements, nor did we have any transfers into or out of Level 3 during the fiscal year ended March 31, 2022.
Nonrecurring Fair Value Measurements
We hold equity investments in certain unconsolidated entities without a readily determinable fair value. Our strategic investments represent less than a 20% ownership interest in each of the privately held entities, and we do not maintain power over or control of the entities. We have elected the practical expedient in Topic 321, Investments-Equity Securities, to measure these investments at cost less any impairment, adjusted for observable price changes, if any. Based on these considerations, we estimate that the carrying value of the acquired shares represents the fair value of the investment. At March 31, 2022, we held approximately $20,000 of such investments in Other assets within our Consolidated Balance Sheet.
During the fiscal year ended March 31, 2021, we recognized a gain on the sale of one of these investments of $40,588. The gain is reflected in Gain (loss) on long-term investments, net within our Consolidated Statements of Operations.